Source: Murray Wiseman Authors: Scholz, Derwand, Zelenko
A discussion of a retrospective study early risk-stratified treatment of Covid-19 outpatients with zinc plus low-dose hydroxychloroquine and azithromycin, including the observation of opposition by authorities to the use of the study’s treatment.
Zelenko’s Protocol explained: over 2200 outpatients treated with 99.7% survival rate
Dr. Vladimir Zelenko Speaks Openly On Hydroxychloroquine with Dr. Drew